Indication

Treatment of active ankylosing spondylitis in adult patients who have responded inadequately to conventional therapy.

Medicine details

Medicine name:
upadacitinib (Rinvoq)
SMC ID:
SMC2480
Pharmaceutical company
AbbVie Ltd
BNF chapter
Musculoskeletal and joint diseases
Submission type
Full
Publication due date:
TBC
SMC meeting date:
TBC
Patient group submission deadline:
TBC